CHI's Pharma-Bio Partnering Forum: Emerging Diagnostic Partnering & Investment, August 19, 2012, DC

PRLog (Press Release) - May 10, 2012 - The pace of innovation, both technically and in terms of commercialization strategies, continues to accelerate within the field of molecular diagnostics, making the right strategic partnerships critical to the development of promising new technologies and applications. CHI's Emerging Diagnostic Partnering & Investment Forum will bring together exciting early stage companies with decision makers representing pharma, larger biotechs, and VCs, providing an efficient opportunity to learn about emerging technologies and engage in networking, partnering and investment exploration discussions. The forum will take place on August 19, 2012 at the Hyatt Regency Washington on Capitol Hill, Washington, DC.  

LEARN about the latest tools, platforms and applications in molecular diagnostics  

HEAR from innovative technology developers working in cancer, infectious disease and other therapeutic areas  

DISCUSS strategies to leverage alliances and partnerships to bring diagnostics to market  

NETWORK with early stage companies, established diagnostic and platform companies, clinical labs and investors  

EXPLORE potential partnership opportunities through one-on-one meetings  

MAXIMIZE your experience on site with Partner Direct networking software  

View the agenda and register at http://www.NextGenerationDx.com/Dx-Partnering    

As part of the Next Generation Dx Summit (Enabling Point-of-Care Diagnostics, Emerging Molecular Markers of Cancer, Molecular Diagnostics for Infectious Disease, Companion Diagnostics, Commercialization of Molecular Diagnostics, Mass Spec for the Clinic), this event will bring together all of the major players in the evolving areas of diagnostics.    

To inquire about sponsorship/exhibit opportunities, contact Joseph Vacca at 781-972-5431, jvacca@healthtech.com.      

About Cambridge Healthtech Institute (www.chicorporate.com)    

CHI is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing Consultants, Barnett Educational Services, Cambridge Meeting Planners and CHI’s Media Group, which includes news websites and e-newsletters including Bio-IT World and eCliniqua. Founded in 1992, CHI strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments.    

Contact:
James Prudhomme
Cambridge Healthtech Institute
781-972-5400
jprudhomme@healthtech.com